• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Vial launches VialConnect: Modernized CTMS with patient recruitment assistance


The company's VialConnect is an intuitive clinical trials management platform built for coordinators and investigators.

Vial this week announced the debut of VialConnect, an intuitive clinical trials management platform built for coordinators and investigators.

According to the company, VialConnect is offered at no cost and makes it simple for research sites to access Vial’s modernized CTMS and additional services for patient recruitment.

The company noted in a news release that signing up for VialConnect gives sites access to 2 services for free: First, a customizable CTMS (clinical trials management system) that powers core workflows and provides operational visibility. And second, A HIPAA-compliant EMR filtering tool making it easier to sort potential trial subjects.

"Since implementing Vial's CTMS at our sites, our team's day-to-day operations have become faster and more efficient,” Stacey Gomez, a clinical research manager and one of the first users said in a statement. “We can easily schedule new appointments, track patients, and view all of our studies in one place. It's easy to navigate and our team loves it.”

Simon Burns, co-founder and CEO of Vial, noted that the company talked extensively with PIs and CRCs to identify their main pain points — the lack of an intuitive CTMS and an inability to recruit patients efficiently.

VialConnect solves these issues through modernized tech solutions,” he said in the release. “After deploying VialConnect at our 30+ partner sites, it’s clear from their feedback that our CTMS and patient recruitment program wins in all of these areas.”

Vial strives to be a next generation site management organization by providing the necessary resources for research practices to run trials with faster execution and higher quality.

The company has over 90 employees and is based in San Francisco, California.

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
© 2024 MJH Life Sciences

All rights reserved.